GO:2000288 positive regulation of myoblast proliferation: Muscle Regeneration Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000288 describes any process that activates or increases the frequency, rate or extent of myoblast proliferation, a critical step in skeletal muscle growth and repair.
• Myoblast proliferation is driven by transcription factors such as MEF2A, which promotes proliferation and inhibits apoptosis in myoblast cells.
• Signaling pathways including AMPK/ULK1-mediated autophagy and PTEN/AKT are involved in regulating myoblast proliferation and differentiation.
• Dysregulation of myoblast proliferation contributes to neuromuscular disorders, sarcopenia, and impaired muscle regeneration.
• Key genes studied in this context include MEF2A, PBK, SRPX2, and NEU3B, each with distinct roles in myoblast biology.
• CRISPR-based knockout, knock-in, and overexpression models enable causal interrogation of genes that positively regulate myoblast proliferation.
Description
Skeletal muscle regeneration depends on the activation and proliferation of myoblasts, the committed muscle precursor cells that ultimately fuse to form multinucleated myofibers. The Gene Ontology term GO:2000288, positive regulation of myoblast proliferation, captures the biological processes that stimulate this proliferative expansion. Understanding this term is essential for researchers studying muscle development, regeneration, and diseases characterized by muscle wasting or impaired repair. Myoblast proliferation is not a single molecular event but a coordinated outcome of transcription factor activity, growth factor signaling, metabolic regulation, and cell-cycle progression. For example, the transcription factor MEF2A has been shown to positively regulate myoblast proliferation while suppressing apoptosis, and the kinase PBK enhances myoblast differentiation and muscle regeneration through AMPK/ULK1-mediated autophagy. These findings illustrate the diversity of mechanisms that converge on the positive regulation of myoblast proliferation. For biomedical researchers, GO:2000288 provides a structured framework to annotate gene function, interpret transcriptomic and proteomic data, and design experiments that test causality. Whether the goal is to identify therapeutic targets for sarcopenia or to optimize cultured meat production, precise manipulation of myoblast proliferation is a central objective.
positive regulation of myoblast proliferation At A Glance
| GO ID | GO:2000288 |
|---|---|
| GO term | positive regulation of myoblast proliferation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Activates or increases the frequency, rate or extent of myoblast proliferation |
| Related processes | Myoblast differentiation, muscle regeneration, autophagy, apoptosis |
| Key regulators | MEF2A, PBK, PTEN/AKT, AMPK/ULK1 |
| Disease relevance | Neuromuscular disorders, sarcopenia, osteoporosis |
What Is GO:2000288?
GO:2000288, positive regulation of myoblast proliferation, is defined as any process that activates or increases the frequency, rate or extent of myoblast proliferation. In other words, it encompasses all molecular and cellular events that lead to an increase in the number of myoblasts through cell division. This term is a biological process annotation used to describe gene products that promote, rather than inhibit, myoblast expansion.
Why Is positive regulation of myoblast proliferation Important in Cell Biology?
Positive regulation of myoblast proliferation is fundamental to skeletal muscle homeostasis and repair. After injury, satellite cells must proliferate extensively to generate enough myoblasts for effective regeneration. When this process is impaired, muscle regeneration fails, contributing to conditions such as neuromuscular disorders and age-related sarcopenia. Conversely, excessive or dysregulated myoblast proliferation can contribute to pathological states. Therefore, understanding the positive regulation of myoblast proliferation offers insights into both normal physiology and disease, and provides a rationale for developing targeted therapies.
• Essential for skeletal muscle regeneration after injury or exercise.
• Dysregulation contributes to neuromuscular disorders and satellite cell-opathies.
• Implicated in age-related muscle loss (sarcopenia) and impaired mitochondrial homeostasis.
• MEF2A positively regulates myoblast proliferation and inhibits apoptosis, linking transcription to cell survival.
• PBK promotes myoblast differentiation and muscle regeneration via AMPK/ULK1-mediated autophagy.
• PTEN/AKT signaling is modulated by exosomal miR-92a-3p to influence myoblast behavior and bone metabolism.
• Metformin and miR-378a-3p influence C2C12 myoblast proliferation under hyperglycemia.
• SRPX2 gene therapy affects fibroblast-to-myofibroblast transition, highlighting broader roles in tissue remodeling.
• Neu3b sialidase positively regulates myoblast differentiation through ganglioside desialylation.
• CRISPR screening can identify novel positive regulators of myoblast proliferation for therapeutic targeting.
What Happens During positive regulation of myoblast proliferation?
Activation of Myogenic Transcription Factors
In simple terms: Certain proteins act like switches that turn on genes needed for myoblast division.
Positive regulation of myoblast proliferation often begins with the activation of transcription factors such as MEF2A. In bovine myoblast cells, MEF2A expression promotes proliferation and inhibits apoptosis, indicating a direct role in positively regulating myoblast expansion. Similarly, MEF2A is involved in mitochondrial homeostasis and muscle regeneration during sarcopenia, further supporting its role in proliferative control.
Growth Factor and Signaling Pathway Activation
In simple terms: External signals bind to receptors on the myoblast surface and trigger internal cascades that drive cell division.
Signaling pathways such as PTEN/AKT and AMPK/ULK1 are central to myoblast proliferation. Exosomal miR-92a-3p from mechanically stressed C2C12 cells modulates the PTEN/AKT pathway, influencing osteogenesis and potentially myoblast behavior. PBK positively regulates myoblast differentiation and muscle regeneration by enhancing AMPK/ULK1-mediated autophagy, which is required for proper proliferative expansion.
Metabolic and Autophagic Control
In simple terms: Cells recycle their own components to provide energy and building blocks for rapid division.
Autophagy is a catabolic process that supports myoblast proliferation by maintaining energy homeostasis. PBK enhances AMPK/ULK1-mediated myogenic autophagy, which is necessary for myoblast differentiation and muscle regeneration. This links metabolic stress sensing to the positive regulation of myoblast proliferation.
Cell Cycle Progression and Survival
In simple terms: Myoblasts must pass through the cell cycle and avoid programmed cell death to increase in number.
Positive regulation of myoblast proliferation requires both cell cycle entry and suppression of apoptosis. MEF2A expression in bovine myoblasts promotes proliferation and reduces apoptosis. Additionally, miR-378a-3p participates in metformin's mechanism of action on C2C12 cells under hyperglycemia, affecting proliferation and survival.
Extracellular Matrix and Membrane Remodeling
In simple terms: Changes to the cell surface and surrounding matrix allow myoblasts to respond to growth signals.
Ganglioside desialylation by Neu3b sialidase positively regulates myoblast differentiation, indicating that membrane lipid remodeling contributes to myoblast biology. SRPX2, a secreted protein, influences fibroblast-to-myofibroblast transition and may similarly affect the myoblast niche.
Key Genes Involved in GO:2000288 positive regulation of myoblast proliferation
The following genes and proteins have been experimentally linked to the positive regulation of myoblast proliferation or closely related processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MEF2A | Transcription factor promoting myoblast proliferation and inhibiting apoptosis | Knockout and overexpression studies in bovine and mouse myoblasts |
| PBK | Kinase enhancing AMPK/ULK1-mediated autophagy and muscle regeneration | Knockdown and overexpression in myoblast differentiation models |
| PTEN | Phosphatase antagonizing AKT signaling; modulated by miR-92a-3p | Exosome studies and AKT pathway analysis |
| AKT | Serine/threonine kinase promoting cell survival and proliferation | Phosphorylation assays and pathway inhibitors |
| AMPK | Energy sensor activating ULK1 and autophagy | Metabolic stress and autophagy flux assays |
| ULK1 | Autophagy-initiating kinase downstream of AMPK | Autophagy flux and knockout studies |
| SRPX2 | Secreted protein involved in cell migration and tissue remodeling | Gene therapy and fibroblast transition models |
| NEU3B | Sialidase that desialylates gangliosides | Enzyme activity assays and differentiation models |
| miR-92a-3p | MicroRNA targeting PTEN in exosome-mediated signaling | Exosome transfer and luciferase reporter assays |
| miR-378a-3p | MicroRNA involved in metformin response under hyperglycemia | C2C12 myoblast culture and miRNA mimics |
| MyoD | Master myogenic transcription factor | Differentiation and proliferation assays |
| Myf5 | Myogenic determination factor | Satellite cell activation studies |
| Pax7 | Satellite cell marker and regulator | Lineage tracing and knockout models |
| MEF2C | Transcription factor in muscle development | Overexpression and knockdown |
| IGF-1 | Growth factor promoting myoblast proliferation | Exogenous treatment and signaling assays |
| FGF2 | Growth factor stimulating myoblast proliferation | Culture supplementation and receptor inhibition |
| HGF | Hepatocyte growth factor activating satellite cells | Satellite cell activation assays |
| IL-6 | Cytokine modulating muscle regeneration | Inflammatory models and myoblast culture |
How Is positive regulation of myoblast proliferation Regulated?
Positive regulation of myoblast proliferation is controlled by a network of transcription factors, signaling kinases, and microRNAs. MEF2A acts as a positive regulator by promoting proliferation and inhibiting apoptosis. The PTEN/AKT pathway is modulated by exosomal miR-92a-3p, which can influence myoblast behavior. AMPK/ULK1-mediated autophagy, enhanced by PBK, supports the metabolic demands of proliferating myoblasts. Additionally, miR-378a-3p participates in metformin's effects on C2C12 cells under hyperglycemia, linking metabolic stress to proliferative control. These regulatory layers ensure that myoblast proliferation is tightly coupled to environmental cues and energy status.
positive regulation of myoblast proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MEF2A | Sarcopenia, muscle regeneration | MEF2A knockout and overexpression in C2C12 myoblasts |
| PBK | Muscle regeneration, autophagy | PBK knockdown and AMPK/ULK1 inhibition in myoblasts |
| PTEN | Osteoporosis, AKT signaling | Exosome transfer and PTEN knockout myoblasts |
| SRPX2 | Pulmonary fibrosis, fibroblast transition | SRPX2 gene therapy in fibrosis models |
| NEU3B | Myoblast differentiation, ganglioside metabolism | Neu3b overexpression and sialidase assays |
Neuromuscular Disorders and Satellite Cell Dysfunction
Impaired positive regulation of myoblast proliferation contributes to neuromuscular disorders characterized by satellite cell dysfunction. Ganassi et al. (2022) describe how defects in satellite cell activation and proliferation underlie a spectrum of satellite cell-opathies, leading to progressive muscle weakness and wasting. Understanding the positive regulators of myoblast proliferation is therefore critical for developing therapies that restore regenerative capacity.
Sarcopenia and Age-Related Muscle Loss
Sarcopenia, the age-related loss of muscle mass and function, is associated with dysregulated myoblast proliferation and mitochondrial homeostasis. MEF2A has been implicated in mitochondrial homeostasis and muscle regeneration during sarcopenia, suggesting that positive regulation of myoblast proliferation is protective against age-related muscle decline.
Osteoporosis and Muscle-Bone Crosstalk
Mechanical stress-induced C2C12-derived exosomes carrying miR-92a-3p modulate the PTEN/AKT pathway to affect osteoporosis, highlighting a crosstalk between myoblast proliferation and bone metabolism. This suggests that positive regulation of myoblast proliferation may have systemic effects on skeletal health.
Pulmonary Fibrosis and Tissue Remodeling
SRPX2, a gene studied in the context of myoblast-related processes, has been targeted in gene therapy for pulmonary fibrosis by blocking fibroblast-to-myofibroblast transition. While not a muscle disease, this illustrates how regulators of myoblast biology can influence fibrotic remodeling in other tissues.
From positive regulation of myoblast proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MEF2A positively regulate myoblast proliferation? | MEF2A knockout and overexpression in C2C12 cells |
| What is the role of PBK in autophagy-mediated myoblast proliferation? | PBK knockdown with AMPK/ULK1 inhibitors |
| How does exosomal miR-92a-3p affect PTEN/AKT in myoblasts? | Exosome treatment and PTEN luciferase reporter |
| Does Neu3b sialidase enhance myoblast differentiation? | Neu3b overexpression and ganglioside analysis |
| Can SRPX2 gene therapy modulate fibrosis? | Liposomal SRPX2 delivery in pulmonary fibrosis models |
| How does metformin affect myoblast proliferation under hyperglycemia? | C2C12 cells with miR-378a-3p mimics |
How to Study the positive regulation of myoblast proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify positive regulators of myoblast proliferation |
| Proteomics | Protein abundance and modifications | Discover signaling changes in myoblasts |
| Autophagy flux assay | LC3B-II and p62 levels | Assess AMPK/ULK1-mediated autophagy |
| Exosome isolation | Exosomal miRNA content | Study miR-92a-3p transfer to myoblasts |
| Luciferase reporter | miRNA target validation | Confirm PTEN as a miR-92a-3p target |
| EdU incorporation | DNA synthesis and proliferation | Quantify myoblast proliferation |
| Western blot | Protein phosphorylation and expression | Measure AKT, AMPK, ULK1 activity |
| Immunofluorescence | Protein localization and markers | Visualize MyoD, Pax7 in myoblasts |
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics can identify genes and proteins differentially expressed during positive regulation of myoblast proliferation. For example, MEF2A target genes have been profiled in bovine myoblasts to reveal proliferation and apoptosis pathways. Such datasets can be annotated with GO:2000288 to prioritize candidates.
Autophagy and Metabolic Assays
Measuring autophagy flux using LC3B and p62, combined with AMPK/ULK1 phosphorylation, assesses the metabolic regulation of myoblast proliferation. PBK studies have used these assays to link autophagy to muscle regeneration.
Exosome and microRNA Functional Studies
Exosome isolation, microRNA mimics, and luciferase reporters can test how exosomal miRNAs such as miR-92a-3p modulate PTEN/AKT signaling in myoblasts. Similar approaches apply to miR-378a-3p under hyperglycemia.
Imaging and Proliferation Assays
EdU incorporation, Ki67 staining, and live-cell imaging quantify myoblast proliferation. These methods are standard for validating positive regulators identified by CRISPR screens or transcriptomics.
How CRISPR Can Be Used to Study GO:2000288 positive regulation of myoblast proliferation
Knockout
CRISPR knockout of candidate genes such as MEF2A or PBK in myoblast cell lines can determine whether they are required for positive regulation of myoblast proliferation. Loss-of-function phenotypes are assessed by proliferation assays and autophagy flux.
Point Mutation
Introducing point mutations in kinase domains of PBK or phosphorylation sites of MEF2A can dissect specific residues required for proliferative signaling. Such models help distinguish catalytic activity from scaffolding functions.
Knock-in
Knock-in of fluorescent tags or epitope tags at endogenous loci enables real-time tracking of proteins like MEF2A during myoblast proliferation. This approach preserves native regulation and allows imaging of protein dynamics.
Overexpression
CRISPR activation or lentiviral overexpression of genes such as SRPX2 or NEU3B can test sufficiency for promoting myoblast proliferation. Overexpression models are useful for identifying gain-of-function phenotypes.
How EDITGENE Supports positive regulation of myoblast proliferation Research
Researchers studying positive regulation of myoblast proliferation-related genes often need to determine whether a candidate gene is causally involved in driving or sustaining myoblast expansion. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from knockout to knock-in and overexpression, as well as library screening and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of myoblast proliferation research.
Frequently Asked Questions About positive regulation of myoblast proliferation
What is GO:2000288 positive regulation of myoblast proliferation?
GO:2000288 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of myoblast proliferation.
What genes are involved in positive regulation of myoblast proliferation?
Key genes include MEF2A, PBK, PTEN, AKT, AMPK, ULK1, SRPX2, and NEU3B, as well as microRNAs such as miR-92a-3p and miR-378a-3p.
How does MEF2A regulate myoblast proliferation?
MEF2A promotes myoblast proliferation and inhibits apoptosis, as shown in bovine myoblast cells. It is also involved in mitochondrial homeostasis during sarcopenia.
What is the role of PBK in myoblast proliferation?
PBK positively regulates myoblast differentiation and muscle regeneration by enhancing AMPK/ULK1-mediated autophagy.
How is PTEN involved in myoblast proliferation?
PTEN is a phosphatase that antagonizes AKT signaling and is targeted by exosomal miR-92a-3p, influencing myoblast behavior and osteoporosis.
What diseases are associated with dysregulated myoblast proliferation?
Neuromuscular disorders, sarcopenia, osteoporosis, and pulmonary fibrosis have been linked to altered myoblast proliferation or related processes.
How can CRISPR be used to study positive regulation of myoblast proliferation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes in myoblast cell lines.
What methods measure myoblast proliferation?
EdU incorporation, Ki67 staining, RNA-seq, proteomics, and autophagy flux assays are commonly used.
What is the role of autophagy in myoblast proliferation?
Autophagy, regulated by AMPK/ULK1, supports the metabolic demands of proliferating myoblasts and is enhanced by PBK.
How does metformin affect myoblast proliferation?
Metformin's mechanism of action on C2C12 cells under hyperglycemia involves miR-378a-3p, which participates in regulating proliferation.
Conclusion
GO:2000288 positive regulation of myoblast proliferation is a central biological process in skeletal muscle regeneration and homeostasis. Its dysregulation contributes to neuromuscular disorders, sarcopenia, and other muscle-related pathologies. Key regulators such as MEF2A, PBK, and the PTEN/AKT and AMPK/ULK1 pathways provide mechanistic insights and therapeutic targets. By leveraging CRISPR-based knockout, knock-in, and overexpression models, researchers can causally interrogate these regulators. EDITGENE offers end-to-end services to accelerate discovery in this field, from library screening to bioinformatics, enabling precise annotation and manipulation of GO:2000288-related genes.
References
- 1. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 2. Xu N et al.. 2023. Therapeutic Effects of Mechanical Stress-Induced C2C12-Derived Exosomes on Glucocorticoid-Induced Osteoporosis Through miR-92a-3p/PTEN/AKT Signaling Pathway.. Int J Nanomedicine 18:7583-7603 PMID: 38106447
- 3. Tao X et al.. 2026. A novel role of Mef2a in mitochondrial homeostasis and muscle regeneration during sarcopenia.. Cells Dev 185:204063 PMID: 41390124
- 4. Shiozaki K et al.. 2016. Positive regulation of myoblast differentiation by medaka Neu3b sialidase through gangliosides desialylation.. Biochimie 123:65-72 PMID: 26805383
- 5. Wang D et al.. 2025. Pbk positively regulates myoblast differentiation and muscle regeneration via enhancing AMPK/ULK1 mediated myogenic autophagy.. J Transl Med 23(1):1144 PMID: 41121382
- 6. Sun J et al.. 2023. Effect of Bovine MEF2A Gene Expression on Proliferation and Apoptosis of Myoblast Cells.. Genes (Basel) 14(7) PMID: 37510401
- 7. Wang Q et al.. 2021. Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition.. Theranostics 11(14):7110-7125 PMID: 34093874
- 8. Machado IF et al.. 2021. miR-378a-3p Participates in Metformin's Mechanism of Action on C2C12 Cells under Hyperglycemia.. Int J Mol Sci 22(2) PMID: 33430391
